Brain Imaging Study of PDE4B Using a Radioactive Tracer
This research study uses a special radioactive tracer and imaging machines (PET and MRI scans) to take pictures of a specific protein in your brain called PDE4B. This is an early-stage study to see if this imaging method works safely and can help us understand brain chemistry in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Be in generally good health with normal blood work and heart rhythm tests
- Have no history of seizures (except childhood fevers) or serious brain conditions
- Be able to lie still inside an MRI scanner for at least 2 hours without claustrophobia
- No metal implants in your body (pacemakers, dental implants, aneurysm clips, cochlear implants, metal pins, etc.)
- Able to travel to the NIH Clinical Center in Bethesda, Maryland for the study visit
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special imaging agent called 11C-JMJ-129 to see how it behaves in the brain and body of healthy volunteers. The goal is to better understand a brain protein called PDE4D, which may be linked to mood and anxiety disorders.
This study uses a special PET scan to look at a brain protein called PDE4 in people with Alzheimer's disease or mild cognitive impairment. It may help researchers understand how this protein is involved in memory and thinking problems.
This study uses a special PET scan to look at the brain chemical norepinephrine, which may be linked to mood and anxiety. It helps researchers understand how the brain works by taking detailed pictures.
This Phase 1 study uses a PET brain scan tracer to see how a specific brain target (PDE4B) is involved in major depressive disorder (MDD). It’s mainly testing whether the imaging approach works and what it shows in people with depression who meet specific safety and medication rules.
This study uses a special imaging tracer to see how it moves through the body and brain. It may help researchers understand brain changes in Parkinson's disease and related conditions.
This Phase 1 study tests a PET scan to measure inflammation-related changes in the brain using a medication called ketoprofen. It may help researchers understand which people with certain brain diseases could benefit from treatments aimed at inflammation.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.